Integra LifeSciences(IART) - 2025 Q3 - Quarterly Results

News Release Integra LifeSciences Reports Third Quarter 2025 Financial Results PRINCETON, N.J., October 30, 2025 - Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2025. Third Quarter 2025 Highlights Codman Specialty Surgical (~70% of Revenues) Total revenues were $292.6 million, representing reported growth of 8.1% and organic growth of 7.1% compared to the third quarter of 2024 ...